Healthcare Services Group (HCSG) Q4 2024 earnings summary

Executive summary

• Q4 2024 marked a pivotal shift from recovery to renewed growth, with strong momentum heading into 2025.

• Revenue for Q4 was $437.8 million, net income $11.9 million, and diluted EPS $0.16, inclusive of $3–$4 million in new business startup costs.

• Cash flow from operations was $36.2 million, or $27 million excluding payroll accrual changes.

• Industry fundamentals are strengthening, with demographic tailwinds and rising demand for long-term and post-acute care services.

Financial highlights

• Q4 revenue: $437.8 million; net income: $11.9 million; diluted EPS: $0.16.

• Year-over-year, Q4 revenue increased from $423.8 million to $437.8 million.

• Q4 net income declined to $11.9 million from $23.5 million in Q4 2023; diluted EPS fell to $0.16 from $0.32.

• Adjusted EBITDA for Q4 was $20.2 million (4.6% of revenue), down from $38.8 million (9.1%) in Q4 2023.

• Cost of services: $379.2 million (86.6% of revenue), including startup costs.

Outlook and guidance

• 2025 revenue expected to grow mid-single digits; Q1 revenue guidance: $440–$450 million.

• 2025 cash flow from operations (excluding payroll accrual): $45–$60 million.

• Cost of services targeted at 86%; SG&A targeted at 8.5–9.5%, though near-term tracking at 9.5–10.5%.

• Mid-single-digit top-line growth expected over the next 3–5 years.